NPT
MRNA icon

National Philanthropic Trust’s Moderna MRNA Stock Holding History

National Philanthropic Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$376K Hold
5,366
– – 0.01% 329
2026
Q1 		$273K Buy
+5,366
New +$250K ﹤0.01% 323
2025
Q1 		– Sell
-5,430
Closed -$226K – 278
2024
Q4 		$226K Hold
5,430
– – ﹤0.01% 253
2024
Q3 		$363K Sell
5,430
-140
-3% -$12.9K 0.01% 208
2024
Q2 		$661K Buy
5,570
+2,029
+57% +$257K 0.01% 180
2024
Q1 		$377K Sell
3,541
-204
-5% -$20.6K 0.01% 215
2023
Q4 		$372K Buy
+3,745
New +$315K 0.01% 226

Other funds holding MRNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

National Philanthropic Trust's MRNA Position: Q2 2026 in Review

National Philanthropic Trust held its Moderna (MRNA) position steady in Q2 2026 at 5,366 shares worth $376K. The position accounts for 0.01% of the portfolio, ranked #329.

National Philanthropic Trust first reported a position in MRNA in Q4 2023 and has held it in 7 quarters since. The position peaked at $661K in Q2 2024. 730 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • National Philanthropic Trust held 5,366 shares of Moderna worth $376K as of Q2 2026.
  • National Philanthropic Trust left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 0.01% of National Philanthropic Trust's portfolio in Q2 2026, its #329 holding.
  • National Philanthropic Trust first reported a position in Moderna in Q4 2023 and has held it in 7 quarters since.
  • National Philanthropic Trust's Moderna position peaked at $661K in Q2 2024.
  • 730 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on National Philanthropic Trust's 13F filing for Q2 2026, filed 14 Aug 2026.